Thiazide-sensitive NaCl-cotransporter in the Intestine

• Published in: The Journal of biological chemistry Vol. 280; no. 20; pp. 19902 - 19910
• Main Authors: Bazzini, Claudia, Vezzoli, Valeria, Sironi, Chiara, Dossena, Silvia, Ravasio, Andrea, De Biasi, Silvia, Garavaglia, MariaLisa, Rodighiero, Simona, Meyer, Giuliano, Fascio, Umberto, Fürst, Johannes, Ritter, Markus, Bottà, Guido, Paulmichl, Markus
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 20.05.2005; American Society for Biochemistry and Molecular Biology
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M411961200

Thiazides, such as hydrochlorothiazide (HCTZ), are used to control blood pressure and to reduce renal calcium excretion. These effects are a result of interactions with the NaCl-cotransporter (NCC). This is demonstrated by the fact that mutations within the NCC protein lead to salt-resistant hypotension and hypocalciuria, paralleled by an increase in bone mineral density. These symptoms are also known as Gitelman syndrome. It has become increasingly evident that the effect of HCTZ on blood pressure and calcium homeostasis cannot be attributed exclusively to kidney functions, where the primary action of HCTZ on NCC is postulated to occur. We demonstrated the presence of the NCC transporter in the rat small intestine (ileum and jejunum) and human HT-29 cells, by using reverse transcription-PCR, Northern blot, Western blot, and immunofluorescence. Furthermore, we show that HCTZ modulates Ca2+ uptake by intestinal cells, while affecting the electrical parameters of the cellular membrane, thus suggesting a functional interaction between NCC and the epithelial voltage-dependent calcium channel. The experiments presented here support the hypothesis of a direct involvement of the intestinal cells in the interaction between HCTZ and NaCl, as well as calcium homeostasis.